| Document Date: 2013-05-01 16:59:55
Open Document File Size: 584,76 KBShare Result on Facebook
City Reference / / Company Placebo Group / GlaxoSmithKline / / Currency pence / / Event FDA Phase / Product Recall / Product Issues / / IndustryTerm prevention of prostate cancer / food / / MedicalCondition Neoplasms / hypospadias / BPH / Cancer / Cardiac Failure / Carcinogenesis / erectile dysfunction / dysfunction / high-grade prostate cancer / acute urinary retention / sexual dysfunction / Male breast cancer / ejaculation disorder / urticaria / angioedema / Diseases / disorder / ejaculation disorders / clinically significant hypersensitivity / benign prostatic hyperplasia / Hypersensitivity / irritation / dizziness / deficiency / prostate cancer / pruritus / impotence / Other Urological Diseases / rash / breast cancer / breast disorders / gynecomastia / / MedicalTreatment surgery / / Organization FDA / / / Position Major / / Product Soft Gelatin Capsules / finasteride / Digoxin / tamsulosin / testosterone / Gelatin Capsules / Trial / DOSAGE AND ADMINISTRATION The capsules / Cholestyramine / AVODART / PROSCAR / / Technology alpha / Pharmacokinetics / Cancer Detection / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART.